West Pharmaceutical Services Inc. buy Citigroup Inc.
Start price
08.01.25
/
50%
€326.40
Target price
08.01.26
€388.28
Performance (%)
-28.37%
End price
09.01.26
€233.80
Summary
This prediction ended on 09.01.26 with a price of €233.80. The price of West Pharmaceutical Services Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.37%. Dividends of €0.20 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | 6.307% | 6.307% | 31.005% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Citigroup_Inc_ for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten